Abstract
Objective: To evaluate how the use of a within-encounter SDM tool (compared to usual care in a randomized trial) contributes to care plans that make sense to patients with atrial fibrillation considering anticoagulation. Methods: In a planned subgroup of the trial, 123 patients rated post-encounter how much sense their decided-upon care plan made to them and explained why. We explored how sense ratings related to observed patient involvement (OPTION12), patient's decisional conflict, and adherence to their plan based on pharmacy records. We analyzed patient motives using Burke's pentad. Results: Plan sensibility was similarly high in both arms (Usual care n = 62: mean 9.4/10 (SD 1.0) vs SDM tool n = 61: 9.2/10 (SD 1.5); p =.8), significantly and weakly correlated to decisional conflict (rho = −0.28, p =.002), but not to OPTION12 or adherence. Plans made sense to most patients given their known efficacy, safety and what is involved in implementing them. Conclusion: Adding an effective intervention to promote SDM did not affect how much, or why, care plans made sense to patients receiving usual care, nor patient adherence to them. Practice Implications: Evaluating the extent to which care plans make sense can improve SDM assessments, particularly when SDM extends beyond selecting from a menu of options.
Original language | English |
---|---|
Pages (from-to) | 1539-1544 |
Number of pages | 6 |
Journal | Patient Education and Counseling |
Volume | 105 |
Issue number | 6 |
Early online date | 9 Oct 2021 |
DOIs | |
Publication status | Published - Jun 2022 |
Bibliographical note
Funding Information:NHLBI (RO1 HL131535?01) & Dutch Research Council; The Netherlands Organisation for Health Research and Development (016.196.138).The trial was funded by and conducted independently of the National Heart, Lung, and Blood Institute (NHLBI) of the U.S. National Institutes of Health (RO1 HL131535?01). The funding body had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Funding Information:
The trial was funded by and conducted independently of the National Heart, Lung, and Blood Institute (NHLBI) of the U.S. National Institutes of Health ( RO1 HL131535–01 ). The funding body had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Publisher Copyright:
© 2021 The Authors
Funding
NHLBI (RO1 HL131535?01) & Dutch Research Council; The Netherlands Organisation for Health Research and Development (016.196.138).The trial was funded by and conducted independently of the National Heart, Lung, and Blood Institute (NHLBI) of the U.S. National Institutes of Health (RO1 HL131535?01). The funding body had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The trial was funded by and conducted independently of the National Heart, Lung, and Blood Institute (NHLBI) of the U.S. National Institutes of Health ( RO1 HL131535–01 ). The funding body had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Funders | Funder number |
---|---|
National Institutes of Health | |
National Heart, Lung, and Blood Institute | R01HL131535 |
ZonMw | 016.196.138 |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek |
Keywords
- Anticoagulation
- Atrial fibrillation
- Communication
- Conversation aid
- Decision aid
- Medication uptake
- Reflection
- Shared decision making